Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MEGF8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | VPS26B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SEC11A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CNGA4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | DVL1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PCDHA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | AGER | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | NDUFAF2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | KLHL18 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SCARF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |